Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01952132
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects
Condition: Schizophrenia
Interventions: Drug: OMS643762;   Drug: Placebo

Indicates status has not been verified in more than two years